Literature DB >> 21300707

Switzerland is to fund complementary therapies for six years while effectiveness is evaluated.

Ned Stafford.   

Abstract

Mesh：

Year:  2011        PMID： 21300707     DOI： 10.1136/bmj.d819

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

Review 1.  How Phages Overcome the Challenges of Drug Resistant Bacteria in Clinical Infections.

Authors:  Majid Taati Moghadam; Nour Amirmozafari; Aref Shariati; Masoumeh Hallajzadeh; Shiva Mirkalantari; Amin Khoshbayan; Faramarz Masjedian Jazi
Journal:  Infect Drug Resist       Date:  2020-01-07       Impact factor: 4.003

Review 2.  A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens.

Authors:  Xavier Wittebole; Sophie De Roock; Steven M Opal
Journal:  Virulence       Date:  2013-08-13       Impact factor: 5.882

Review 3.  Proteus mirabilis Biofilm: Development and Therapeutic Strategies.

Authors:  Reham Wasfi; Samira M Hamed; Mai A Amer; Lamiaa Ismail Fahmy
Journal:  Front Cell Infect Microbiol       Date:  2020-08-14       Impact factor: 5.293
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.